Results 221 to 230 of about 7,436,963 (336)

The role of T cells in the treatment of Parkinson's disease. [PDF]

PeerJ
Lin Z, Yu X, Zhong Y, Tan G, Zhong J.
europepmc   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

T Cells Dysfunction in Multiple Myeloma. [PDF]

Immunotargets Ther
Cai L, Zuo L, Wang G, Li Q, Ma C, Wu J, Sun C, Hu Y.   +7 more
europepmc   +1 more source

Immune‐ and non‐immune‐mediated roles of regulatory T‐cells during wound healing [PDF]

, 2019
Dietmar M. Zaiss, Carlos M. Minutti, Johanna A. Knipper   +2 more
openalex   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

GPX4 is a key ferroptosis regulator orchestrating T cells and CAR-T-cells sensitivity to ferroptosis. [PDF]

Cancer Immunol Immunother
Kłopotowska M, Baranowska I, Hajduk S, Jurga A, Leśniowska N, Łaźniewski M, Granica M, Krawczyk M, Dziewicka M, Graczyk A, Słupski J, Zagożdżon R, Plewczynski D, Winiarska M, Bajor M.   +14 more
europepmc   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

Translational values of tissue-resident memory T cells in chronic inflammation and cancer. [PDF]

Clin Transl Med
Duan W, Wang X.
europepmc   +1 more source

Second-Generation Histone Deacetylase 6 Inhibitors Enhance the Immunosuppressive Effects of Foxp3+ T-Regulatory Cells

, 2011
Jay H. Kalin, Kyle V. Butler, Tatiana Akimova, Wayne W. Hancock, Alan P. Kozikowski   +4 more
openalex   +1 more source

Chemotaxis of Vδ2 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis [PDF]

, 2017
Wenxiu Mo, Shanshan Yin, Hua Chen, Chen Zhou, Jiaxin Zhou, Lidan Zhao, Yunyun Fei, Huaxia Yang, Jing-bo Guo, Yujia Mao, Linfang Huang, Wenjie Zheng, Wen Zhang, Jianmin Zhang, Wei He, Xuan Zhang   +15 more
openalex   +1 more source